The Department of Health and Human Services has announced changes to the drug testing panels used in Federal workplace testing programs. The revised panels now include fentanyl and its metabolite norfentanyl, reflecting changes in drug use patterns and safety concerns, particularly related to the opioid crisis. Although there was a proposal to remove MDMA and MDA from the tests due to their low detection rates, this has been postponed for further study. These updates aim to improve the accuracy and relevance of drug tests, balancing scientific evidence, and public input to maintain workplace safety.
Simple Explanation
The Department of Health and Human Services is updating the list of drugs that they check for when testing people who work for the government to make sure everyone is healthy and safe. They added a new drug called fentanyl to the list to help find people who use it because it can be very dangerous.